Human M2e peptide immunogens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8932597
APP PUB NO 20120258077A1
SERIAL NO

13523710

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides novel peptide immunogens comprising influenza virus matrix 2 protein epitopes and related compositions and methods. The present invention relates to a composition comprising a peptide immunogen useful for the prevention and treatment of an influenza virus-mediated disease. The invention also relates to vaccines, immunogenic products and immunogenic compositions containing the peptide immunogens.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THERACLONE SCIENCES INCSEATTLE LIFE SCIENCES BUILDING 1124 COLUMBIA STREE SUITE 300 SEATTLE WA 98104

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mitcham, Jennifer Redmond, US 30 196
Moyle, Matthew Newtown, US 68 592

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 13, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00